Literature DB >> 9825226

Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence.

C S Miller1, R J Danaher, R J Jacob.   

Abstract

The application of molecular biology in the study of the pathogenesis of herpes simplex virus type 1 (HSV-1) has led to significant advances in our understanding of mechanisms that regulate virus behavior in sensory neurons and epithelial tissue. Such study has provided insight into the relationship of host and viral factors that regulate latency, reactivation, and recurrent disease. This review attempts to distill decades of information involving human, animal, and cell culture studies of HSV-1 with the goal of correlating molecular events with the clinical and laboratory behavior of the virus during latency, reactivation, and recurrent disease. The purpose of such an attempt is to acquaint the clinician/scientist with the current thinking in the field, and to provide key references upon which current opinions rest.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825226     DOI: 10.1177/10454411980090040901

Source DB:  PubMed          Journal:  Crit Rev Oral Biol Med        ISSN: 1045-4411


  29 in total

1.  Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up.

Authors:  Carlos de Paula Eduardo; Letícia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques da Graça Lopes; Karen Müller Ramalho; Marina Stella Bello-Silva; Marcella Esteves-Oliveira
Journal:  Lasers Med Sci       Date:  2011-11-16       Impact factor: 3.161

2.  Reactivation from quiescence does not coincide with a global induction of herpes simplex virus type 1 transactivators.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophages.

Authors:  Adam Craig Reichard; Nagarjuna Reddy Cheemarla; Nancy Jane Bigley
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 4.  Laser treatment of recurrent herpes labialis: a literature review.

Authors:  Carlos de Paula Eduardo; Ana Cecilia Corrêa Aranha; Alyne Simões; Marina Stella Bello-Silva; Karen Muller Ramalho; Marcella Esteves-Oliveira; Patrícia Moreira de Freitas; Juliana Marotti; Jan Tunér
Journal:  Lasers Med Sci       Date:  2013-04-13       Impact factor: 3.161

5.  IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Authors:  Ana J Chucair-Elliott; Jeremy Jinkins; Meghan M Carr; Daniel J J Carr
Journal:  Am J Pathol       Date:  2016-08-03       Impact factor: 4.307

6.  Degeneration and regeneration of corneal nerves in response to HSV-1 infection.

Authors:  Ana J Chucair-Elliott; Min Zheng; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-13       Impact factor: 4.799

Review 7.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

8.  Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.

Authors:  Christian Clement; Partha S Bhattacharjee; Manish Kumar; Timothy P Foster; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

9.  Herpesvirus reactivation and socioeconomic position: a community-based study.

Authors:  Raymond P Stowe; M Kristen Peek; Norma A Perez; Deborah L Yetman; Malcolm P Cutchin; James S Goodwin
Journal:  J Epidemiol Community Health       Date:  2009-10-12       Impact factor: 3.710

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.